Atara Biotherapeutics, Inc. (ATRA)
15.64
+0.56
(+3.71%)
USD |
NASDAQ |
Dec 09, 16:00
15.64
0.00 (0.00%)
After-Hours: 20:00
Atara Biotherapeutics Shareholders Equity (Quarterly): -36.63M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 230.42M |
| Pacira Biosciences, Inc. | 727.21M |
| ADMA Biologics, Inc. | 431.19M |
| NovaBay Pharmaceuticals, Inc. | 1.634M |
| Palatin Technologies, Inc. | 0.3964M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 30.17M |
| Total Liabilities (Quarterly) | 66.80M |
| Debt to Equity Ratio | -1.600 |
| Current Ratio | 1.021 |
| Net Debt Paydown Yield | 6.05% |